Sleep and Glycemic Control in Type 2 Diabetes Adolescents

Recruiting now · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving sleep goals can increase sleep duration in 15 adolescent patients diagnosed with T2DM with insufficient sleep. Another secondary objective is to test if increasing sleep duration leads to improved glycemic control in 15 adolescents with T2DM identified in Aim 1 as having \<8 hr sleep/evening. A focus group will be conducted prior to this intervention with patients ineligible for the intervention in order to determine appropriate text messaging.

Key facts

Study ID

NCT04213547

Run by

Children's Hospital of Philadelphia

People needed

90

Starts

2020-09-16

Expected to finish

2028-07-01

Last updated by the study team

2026-06-29

Who can join

Age: 12 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aim 1 for child:
• Subjects age 12-20
• Diagnosed with T2DM by standard laboratory criteria without pancreatic autoimmunity
• Low probability of obstructive sleep apnea (OSA) assessed via validated sleep survey
• Subjects will be included if they are taking T2DM treatments (i.e., diet modification, Metformin and/or insulin)
• Parental/guardian permission and child assent
• Aim 1 for parent:
• Parent or legal guardian of child that meets inclusion criteria for Aim 1.
• Aim 2 for child:
• Completed Aim 1 evaluation
• Average sleep duration < 8 hours per night as determined by actigraphy in Aim 1
• HbA1c ≤ 10% as HbA1c >10 correlates to poor adherence
• Adherence > 80%
• Focus group for child:
• Subjects aged 12-20
• Diagnosed with type 2 diabetes without pancreatic autoimmunity

You may not qualify if…

• Aim 1 for child:
• Non-English speaking subject (as questionnaires used are validated in English)
• Institutionalized patients as sleep duration will not be of their own accord, and therefore is not generalizable to the rest of the adolescent T2DM population.
• Patients with other forms of Diabetes Mellitus (e.g. Type 1 Diabetes)
• Behavioral disorders that may affect data collection (e.g. autism spectrum disorder) will be determined on a case-by-case basis. These include patients that are unable to answer questionnaires on their own, participate in a sleep diary, wear devices and/or understand incentives.
• Oral or IV steroid treatment within the past month
• Females with known pregnancies as these patients will not be generalizable to the rest of the adolescent T2DM population and pregnancy may alter sleep duration.
• Subjects with known hyperthyroidism, pain syndrome, or serious medical condition that can affect sleep.
• Subjects with hemoglobinopathies that affect hemoglobin A1c measurement.
• Unable to obtain point-of-care hemoglobin A1c in clinic on date of recruitment
• Known diagnosis of obstructive sleep apnea or other sleep disorder
• Aim 1 for Parent:
• Non-English speaking subject (as questionnaires used are validated in English)
• Parent/guardians with cognitive disorders that may affect data collection (determined on a case-by-case basis)
• Aim 2 for child:
• Do not own a smart phone or tablet
• Focus group for child:
• Non-English speaking subject (as focus group will be conducted in English)
• Lack of access to a computer, tablet or smartphone that can accommodate participation in video conferencing

Where it is running

• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.